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Abstract Increased 'oxidative stress' resulting in the activation 
of nuclear factor •B (NF-KB) is thought o play a crucial role in 
the cytokine-mediated expression of the inducible isoform of ni- 
tric oxide synthase (iNOS) in different cell types. Therefore, the 
effects of four different antioxidants, carbocromen, chrysin, 3,4- 
dichloroisocoumarin (DCI) and N-acetylserotonin (NAS), on 
iNOS expression were investigated in vascular smooth muscle 
cells (VSMC). All antioxidants strongly reduced the phorbol 
ester-stimulated superoxide anion formation in native VSMC. 
Carbocromen (200 jaM) and chrysin (50 jaM) had no effect, while 
NAS (1 mM) abolished the increase in nitrine production and 
iNOS protein abundance in cultured VSMC exposed to inter- 
leukin-li~ (IL-I~, 60 U/ml) or the adenylyl cyclase activator 
forskolin (10 jaM). DCI also revealed a marked inhibitory effect 
in IL-1/$-stimulated VSMC, but was less effective in cells treated 
with forskolin. DCI, but not NAS, also suppressed the activation 
of NF-IcB in VSMC exposed to IL-I~, while no significant NF- 
KB activation was detected in forskolin-treated cells. These find- 
ings demonstrate that antioxidants differentially affect iNOS 
expression in VSMC both at the transcriptional level by prevent- 
ing the activation of NF-KB and at the post-transcriptional level, 
presumably by promoting iNOS mRNA or protein degradation. 
They also suggest hat reactive oxygen intermediates do not play 
a role in the activation of NF-KB by IL-I~ in VSMC, and that 
transeripton factors other than NF-KB mediate the induction of 
iNOS expression by elevating the intracellular concentration of 
cyclic AMP. 
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1. Introduction 
The high production of nitric oxide (NO) generated by the 
inducible isoform of NO synthase (iNOS), e.g. in macrophages 
and vascular smooth muscle cells (VSMC), can exert both pro- 
tective and deleterious effects [1]. The isoenzyme-specific inhi- 
bition of iNOS expression and/or activity therefore represents 
an important herapeutic goal. 
Changes in NO formation in iNOS-expressing cells are usu- 
ally correlated with similar changes in iNOS mRNA abun- 
dance, indicating that a major part of iNOS regulation occurs 
at the level of transcription, The 5'-flanking region of the iNOS 
gene contains everal bindings sites for cis-regulatory elements 
such as nuclear factor xB (NF-xB) [2~,], and activation of this 
transcription factor has been shown to be critical for iNOS gene 
expression in murine macrophages exposed to bacterial lipopol- 
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ysaccharide (LPS) [5,6] and in interleukin-lfl (IL-lfl)-stimu- 
lated VSMC [7] and mesangial cells [8]. 
Since antioxidants are thought o inhibit the cytokine-mediated 
activation of NF-xB in many cell types [9], we have investigated 
whether these compounds also affect iNOS expression in rat 
aortic VSMC stimulated with IL-lfl. In addition, we have stud- 
ied their effects on iNOS expression in cells exposed to fors- 
kolin, since the induction of iNOS expression by agents which 
elevate the intracellular level of cAMP has been suggested to 
be mediated by transcription factor(s) other than NF-xB [8]. 
2. Materials and methods 
2.1. Materials' 
3-fl-Diethylaminoethyl-4-methyl-7-ethoxycarbonyl-methoxy-couma- 
rin (carbochromen) was obtained from Hoechst; recombinant bo- 
vine superoxide dismutase from Grfinenthal; N-acetylserotonin 
(NAS), chrysin (5,7-dihydroxyflavone), 3,4-dichloroisocoumarin 
(DCI), forskolin, xanthine oxidase and xanthine from Sigma; IL-lfl 
from Collaborative Research; and Ro 31-8220 from Roche Products 
Ltd. 
2.2. Determination of superoxide anion formation 
Aortae were isolated from pentobarbitone-anesthetized male Wistar 
rats (250-300 g body weight), cleaned of adherent adipose and connec- 
tive tissue, and cut into ring segments of approximately 7 mm in length. 
The endothelium was mechanically removed and superoxide anion (02) 
formation determined by monitoring the lucigenin (bis-N-methylacrid- 
inium nitrate)-enhanced chemiluminescence of O2 in a Lumac/3M 
model M2010 biocounter at 37°C. Briefly, the segments were incubated 
in 0.9 ml Hepes-buffered Tyrode solution, pH 7.35 (composition in 
mM: CaC12 1.8, KC1 2.7, MgCI 2 0.5, NaC1 137.0, NaH2PO 4 0.36, 
D-glucose 5.0) in plastic cuvettes to which lucigenin was added at a 
concentration of 250/.tM (final volume 1 ml). After monitoring basal 
O~ formation for 10 min, 1 yM phorbo112-myristate 13-acetate (PMA) 
was added and the difference in chemiluminescence monitored for an- 
other 10 min. The assay was calibrated by monitoring the chemilumi- 
nescence signal of known amounts of 02 generated by xanthine oxidase 
(0.3 10 mU) and xanthine (50/IM). These had been previously deter- 
mined spectrophotometrically by monitoring the reduction of ferricyto- 
chrome c[10]. O2 formation was calculated on the basis of the xanthine 
oxidase/xanthine calibration curve, the incubation time and the wet 
weight of the segments. The chemiluminescence assay was specific for 
O~, no light emission was recorded in the presence of authentic NO 
or  H2O 2. 
2.3. Cell culture 
VSMC were isolated from the thoracic aorta of male Wistar-Kyoto 
rats (30(>350 g body weight) by elastase/collagenase digestion and char- 
acterized by positive immunostaining with monoclonal antibodies 
raised against smooth muscle c~-actin [11]. The cells were serially cul- 
tured in Waymouth medium (PAN Systems) containing non-essential 
amino acids (Biochrom), 100 U/ml of both penicillin and streptomycin, 
and 7.5% (v/v) fetal calf serum (PAN Systems). Upon reaching conflu- 
ence they were passaged by using trypsin-EGTA (0.05/0.02%, w/v). All 
experiments were performed with cells from passages 8-16 seeded into 
60 mm i.d. petri dishes (5 × 10 6 cells/dish) or 24-well plates (3-5 x 105 
cells/well). 
All rights reserved. 
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2.4. Experimental protocol 
Confluent VSMC were incubated either in 0.3 ml (24-well plates) or 
3 ml (60 mm Petri dishes) of serum-free Waymouth medium containing 
0.1% (w/v) BSA in the absence (control cells) or presence of 60 U/ml 
IL-lfl or 10/xM forskolin. When incubations were performed in the 
presence of the antioxidants, these were added together with IL-lfl or 
forskolin. After 20 h in the incubator, the cells were harvested and the 
concentration f nitrite in the conditioned medium (200/21 plus 80 HI 
Griess reagent) was determined photometrically at 570 nm as described 
[12]. In some experiments, incubations were terminated after 30 min to 
prepare nuclear extracts [13]. Cell viability was assessed microscopically 
and by trypan blue exclusion. 
2.5. Electrophoretic mobili O, shij? analysis 
Aliquots of nuclear protein (3/xg) were incubated with an NF-~'B- 
specific oligonucleotide (5'-AGT TGA GGG GAC TTT CCC AGG 
C-Y, [14]; Promega) which was labelled with 32p by random priming 
[15]. Binding experiments were performed with 1~,/11 nuclear extract, 
3 ,ul 5 x binding buffer (50 mM Hepes, pH 7.5, 500 mM NaCI, 25% 
glycerol (w/v), 5 mM EDTA), 1 ,ug poly(dI-dC) as non-specific ompet- 
itor DNA, and the oligonucleotide (5000 cpm) in a total volume of 15 
/21 for 30 min at ambient temperature. Non-denaturing polyacrylamide 
gel (4%) electrophoresis was performed with 1 x TBE buffer, pH 8.0 
followed by autoradiography. To monitor the specificity of the binding 
reaction, the assay was performed in parallel with the same samples in 
the presence of a 100-fold excess of the non-labelled oligonucleotide. 
In some experiments, a supershift analysis was performed by preincuba- 
tion of nuclear extracts from IL-lfl-stimulated VSMC with 1 ,ug of a 
specific polyclonal anti-p65 (RelA) antibody (Santa Cruz Biotechnol- 
ogy) for 12 h at 4°C. 
2.6. Western blot analysis 
Immunoblot analysis of iNOS protein was performed essentially as 
described previously [16]. Protein extracts (10,000xg supernatant) 
were separated by electrophoresis (20/lg protein/lane) on 8%-poly- 
acrylamide gels in the presence of sodium dodecylsulfate and then 
transferred onto nitrocellulose membranes. The loading and transfer of 
equal amounts of protein in each lane was verified by staining of the 
protein bands with Ponceau S (0.2% in 3% trichloroacetic a id, v/v). 
After extensive washing with distilled water to remove the protein stain, 
the immobilized iNOS protein was visualized by subsequent i cubation 
with a polyclonal anti-iNOS antibody (kindly provided by Dr. M. 
Marietta) and a secondary polyclonal peroxidase-conjugated nti-rab- 
bit antibody (Amersham), followed by staining with the enhanced 
chemiluminescence (ECL) technique developed by Amersham. The an- 
tibody was specific for iNOS and did not cross-react with the constitu- 
tive NOS isoforms from rat brain or porcine aortic endothelial cells. 
The intensity of the iNOS-specific bands was quantified by densitom- 
etry (Pharmacia densitometer equipped with a Kappa CCD video cam- 
era and the ImageMaster software). 
2.7. Statisth'al analysis 
Unless indicated otherwise, all data in the figures and text are ex- 
pressed as means + S.E.M. of n experiments with different batches of 
VSMC. Statistical evaluation was performed by one-way analysis of 
variance followed by a Bonferroni t-test for multiple comparisons with 
a P-value <0.05 considered significant. 
3.  Resu l ts  
3.1. Antioxidant activity 
The antioxidative potential of the four antioxidants was 
tested with native VSMC in situ, i.e. in isolated de-endothelial- 
ized segments of the rat aorta, since 02 formation by cultured 
VSMC was frequently found to be below the level of detection 
of the chemiluminescence assay. Exposure of the segments to 
IL-lfl (up to 100 U/ml) did not cause an appreciable increase 
in 0 2 formation for up to 30 min (not shown). Stimulation with 
PMA (1 tiM), however, resulted in a marked increase in 0 2 
formation which was virtually abolished by the protein kinase 
C (PKC) inhibitor Ro 31-8220 (1 tiM; Fig. 1), suggesting that 
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Fig. I. Effects ofcarbocromen (CAR, 200HM), chrysin (CHR. 50/xM), 
DCI (50HM), NAS (1 mM), Ro 31-8220 (Ro 31, 1 ,uM) and superoxide 
dismutase (SOD, 30 nM) on the formation of O2 by native VSMC in 
situ in the absence and presence of PMA (1 HM) as indicated (n = 6 9, 
*P < 0.05 vs. control, i.e. VSMC not exposed to the aforementioned 
drugs). 
the PMA-induced increase in Oi  formation was mediated by 
the activation of PKC. Recombinant bovine superoxide dis- 
mutase (30 nM) also significantly reduced the PMA-dependent 
02 formation, but was less effective than the PKC inhibitor 
(62% inhibition). Carbocromen (200 tiM), chrysin (50 tiM), 
DCI (50 tiM) and NAS (1 mM) also strongly attenuated the 
PMA-induced increase in 02 formation (Fig. 1). Chrysin and 
NAS, but not DCI or carbocromen, also markedly reduced 
(>90% inhibition) the xanthine oxidase (10 mU)/xanthine (50 
tiM)-dependent generation of 02 (not shown). 
3.2. EJ]ects on nitrite production and iNOS protein expression 
Exposure of the cultured VSMC to IL-lfl (60 U/ml) caused 
a time-dependent i crease in nitrite production (as an index of 
iNOS activity), iNOS mRNA and protein abundance which 
peaked at 18 20 h (cf. [17]). Actinomycin D (20 riM) and cyclo- 
heximide (10 tiM) abolished the IL-lfl-induced increase in ni- 
trite production and iNOS protein abundance (not shown), 
confirming that the induction of iNOS gene expression by 
IL-lfl in VSMC requires both DNA transcription and de novo 
protein synthesis. 
Co-incubation of the cells with carbocromen (up to 200/IM) 
or chrysin (up to 50 tiM) did not affect the IL-lfl-induced 
increase in nitrite production (Fig. 2a) or iNOS protein abun- 
dance (not shown). Higher concentrations of these two anti- 
oxidants could not be employed ue to their cytotoxic effects. 
DCI and NAS, on the other hand, suppressed the IL-lfl-in- 
duced increase in nitrite production and iNOS protein abun- 
dance with ICs0 values of 10tiM (Fig. 2a) and 0.5 mM (cf. [18]), 
respectively. In some experiments, DCI and NAS also attenu- 
ated the basal level of nitrite production and iNOS protein 
expression in unstimulated VSMC (not shown). 
Treatment of the cells with forskolin (10 HM) also resulted 
in a prominent increase in nitrite production and iNOS protein 
expression (Fig. 2b), the magnitude of which was comparable 
to the effects exerted by IL-lfl. Co-incubation with NAS, but 
not with carbocromen or chrysin (not shown), virtually abol- 
ished the stimulatory effect of forskolin on nitrite production 
and iNOS protein expression (Fig. 2b). When compared to 
IL-lfl-stimulated VSMC, the inhibitory effect of DCI was much 
less pronounced in forskolin-treated cells (88% and 41% de- 
crease in nitrite production respectively). 
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Fig. 2. (a) Effects of carbocromen (+CAR, 200/,tM), chrysin (+ CHR, 50 pM), DCI (50 pM) and NAS (1 mM) on the increase in nitrite production 
in cultured VSMC exposed to IL-lfl (60 U/ml) for 20 h. 'Basal' denotes the nitrite level in the conditioned medium of VSMC not exposed to iL-lfl 
(n = 5 8, *P < 0.05). (b) Effects ofDCl (50pM) and NAS (1 mM) on the increase in nitrite production i  cultured VSMC exposed to forskolin (FSK, 
10 pM) for 20 h (n = 4~5, *P < 0.05). The immunoblots above the bar charts depict he effects of DCI and NAS on the increase in iNOS protein 
abundance in cultured VSMC exposed to (a) IL-lfl (lane 1, control; lane 2, IL-lfl; lane 3, 1L-lfl + 1 mM NAS; lane 4, lL-lfl + 10 pM DCI; lane 
5, IL-lfl + 25 pM DCI; lane 6, IL-lfl + 50 pM DCI) or (b) forskolin (lane 1, control; lane 2, forskolin; lane 3, forskolin + 1 mM NAS; lane 4, 
forskolin + 50 pM DCI). They are representative of four experiments with different batches of VSMC performed in the same manner. 
NAS is a potent sepiapterin reductase inhibitor [19] and its 
effect on iNOS expression may be related to a lack of tetrahy- 
drobiopterin (BH4), which is an essential co-factor for NO 
biosynthesis [19 22]. Dihydrobiopterin (BH2) is a substrate for 
BH 4 synthesis even under conditions where sepiapterin reduc- 
tase is blocked [19]. To test the hypothesis that NAS blocks 
iNOS expression by limiting the availability of BH 4, VSMC 
were incubated with IL-lfl and BH 2 (0.3 raM), in the absence 
and presence of NAS. BH2 (0.3 raM), however, did not affect 
nitrite production (Fig. 3) and iNOS protein expression (not 
shown) in IL-lfl-stimulated VSMC and failed to reverse the 
inhibitory effects of NAS. 
3.3. Effects on NF-xB  activation 
Two NF-xB-specific DNA-protein complexes were identi- 
fied in nuclear extracts of the cultured VSMC (Fig. 4). While 
the faster migrating complex was also present in extracts of 
control cells, the slower migrating complex was detectable only 
in extracts from IL-lfl-stimulated cells. Treatment of these ex- 
tracts with a specific anti-p65 antibody resulted in a supershift 
of the slower migrating DNA-protein complex, suggesting that 
this complex comprises the p65/p50 heterodimer of NF-KB. 
Consequently, the faster migrating DNA-protein complex is 
likely to represent he p50/p50 homodimer which has been 
previously demonstrated to be present in nuclear extracts of 
VSMC [27]. Moreover, by Western blot analysis we also de- 
tected an increase in p65 protein in nuclear extracts of IL-lfl- 
stimulated VSMC, thus confirming the activation of NF-xB 
(not shown). 
Neither the p65-containing DNA-protein complex nor the 
p50/p50-1ike complex were detectable in nuclear extracts from 
DCI (50 pM)-treated VSMC, suggesting that the coumarin 
derivative abolished both the basal and IL-lfl-mediated activa- 
tion of NF-xB. NAS had no significant effect, while the abun- 
dance of both complexes was increased rather than decreased 
in nuclear extracts of VSMC stimulated with I L-lfl in the pres- 
ence of carbocromen or chrysin (Fig. 4). 
Treatment of the cells with forskolin had either no effect on 
the intensity of the two NF-xB specific DNA-protein com- 
plexes or weakly enhanced that of the p65/p50 heterodimer: the 
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Fig. 3. Effects of dihydrobiopterin (BHz, 0.3 mM) on nitrite production 
in cultured VSMC exposed to IL-lfl (60 U/ml) for 20 h in the absence 
or presence of NAS (1 mM) as indicated (n = 3; *P < 0.05 vs. IL-lfl, 
*P < 0.05 vs. IL-lfl plus BH2). 
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Fig. 4. Effects of carbocromen (200/.tM, lane 6), chrysin (50 ,uM, lane 
5), DCI (50/,tM, lane 4) and NAS (1 mM, lane 3) on the DNA-binding 
activity of NF-xB in nuclear extracts from VSMC exposed to IL-lfl 
(60 U/ml, lane 2) for 30 min (control, lane 1). The gel shift shown is 
representative of five experiments with different batches of VSMC 
performed in the same manner; it also shows the supershift of the slower 
migrating NF-lcB-specific band with the anti-p65 antibody. 
latter effect was reversed in VSMC treated with forskolin and 
DCI (not shown). 
4. Discussion 
The present findings uggest that antioxidants per se have no 
effect on iNOS expression in VSMC. All four test compounds 
strongly diminished the phorbol ester-stimulated, PKC-de- 
pendent formation of 02 in native VSMC in situ. Chrysin and 
NAS also effectively scavenged 02 generated by xanthine oxi- 
dase in vitro. However, only DCI and NAS significantly inhib- 
ited iNOS protein expression in cultured VSMC exposed to 
IL-lfl. Moreover, only DCI inhibited the IL-lfl-induced activa- 
tion of NF-xB. Although these findings confirm that NF-tcB 
activation represents a crucial step in the induction of iNOS 
gene expression in IL-lfl-stimulated VSMC [7], they also sug- 
gest that reactive oxygen intermediates do not play a role in the 
activation of NF-xB in these cells. 
One could argue that the antioxidants employed in the pres- 
ent study are not capable of scavenging reactive oxygen species 
inside the cell and therefore do not block the activation of 
NF-xB. When compared to SOD, which can scavenge 02 only 
outside the cell, three of the test compounds (chrysin, DCI and 
NAS) were clearly more effective in inhibiting the PMA-in- 
duced formation of 02, suggesting that these antioxidants are 
also capable of scavenging intracellular O~-. This notion is sup- 
ported by the finding that lucigenin is taken up by VSMC [24] 
and emits light upon reaction with intracellular 02 [25]. An- 
other argument is that the antioxidants prevent he PMA-in- 
duced formation of O_~, because they interfere with the activa- 
tion of PKC. This possibility, however, is unlikely for the fol- 
lowing reasons: (i) chrysin and NAS scavenged xanthine oxi- 
dase-derived O~; (ii) PMA caused an activation of NF-xB in 
cultured VSMC which was not blocked by chrysin (Hecker et 
al., unpublished observation); and (iii) none of the four antiox- 
idants significantly affected the activity of a semi-purified PKC 
isolated from rat brain (Crause et al., unpublished observation). 
As previously shown for mesangial cells [8], an increase in 
intracellular cAMP alone also causes an expression of the iNOS 
gene in VSMC. Moreover, the partial inhibition by DCI of the 
forskolin-induced increase in nitrite production and iNOS pro- 
tein abundance suggested that in contrast o mesangial cells 
NF-tcB activation may play a role in the cAMP-mediated in- 
crease in iNOS expression in VSMC. However, no significant 
activation of the transcription factor was detected in forskolin- 
treated VSMC, and DCI was clearly less effective in inhibiting 
iNOS expression in VSMC exposed to forskolin as compared 
to IL-lfl-treated cells. It is thus unlikely that NF-xB activation 
plays a major role in the cAMP-mediated increase in iNOS 
expression in VSMC. On the other hand, DCI may affect the 
activation of other transcription factors in response to the rise 
in intracellular cAMP elicited by tbrskolin. 
DCI is a potent serine protease inhibitor and this class of 
compounds has been shown to inhibit NF-xB activation by 
preventing the proteolytic degradation of the inhibitory ItcB 
subunit [26]. It is not clear, however, whether this effect is 
achieved by preventing the targeting of ItcB to the proteasome 
or its degradation by the proteasome, since serine protease 
inhibitors have also been shown to block the phosphorylation 
of IIcB which is crucial for its targeting to the proteasome [27]. 
Irrespective of the precise mechanism of action by which DC1 
prevented the activation of NF-xB in VSMC exposed to IL-lfl, 
this effect is unlikely to be related to its antioxidative properties. 
The finding that NAS did not affect NF-xB activation in 
VSMC points to an effect at the post-transcriptional level, 
presumably involving iNOS mRNA or protein stability. NAS 
is a potent sepiapterin reductase inhibitor and its effect on 
iNOS expression in macrophages,VSMC and mesangial cells 
has been associated with an inhibition of BH 4 synthesis [19 22]. 
BH 4 can be synthesized both by the de novo pathway via GTP 
cyclohydrolase and by the salvage pathway involving sepi- 
apterin reductase. It is not clear, however, whether the avail- 
ability of BHa is rate-limiting both for NO synthesis and iNOS 
expression in cytokine-stimulated VSMC [19,22]. To test this 
hypothesis, the effect of BH2 on the inhibition by NAS of iNOS 
protein expression was investigated, since BH~ is a substrate for 
BH4 synthesis irrespective of a blockade of sepiapterin reduc- 
tase by NAS [19]. As in LPS/interferon-?'-stimulated murine 
macrophages [18], BH 2 failed to reverse the inhibitory effect of 
NAS on iNOS protein expression in IL-lfl-stimulated VSMC, 
suggesting that this effect of NAS is unrelated to the availability 
of BH 4. This notion is also supported by the finding that the 
ICs0 value of NAS for the inhibition ofiNOS protein expression 
in VSMC is 0.5 mM [18], while the halfmaximal concentration 
of NAS required to inhibit sepiapterin reductase activity in rat 
erythrocyte lysates is much lower, i.e. 0.8/,tM (Hecker et al., 
unpublished observation). Moreover, carbocromen, which is 
almost as effective as NAS in inhibiting sepiapterin reductase 
(ICs0 4.0 pM), had no effect on iNOS protein expression in 
VSMC exposed to IL-lfl or forskolin. The precise mechanism 
of action by which NAS inhibits iNOS protein expression in 
activated VSMC thus remains to be elucidated. 
In summary, the present findings show that only certain 
antioxidants inhibit iNOS expression in cultured VSMC either 
by preventing the activation of NF-xB or by promoting the 
degradation of iNOS mRNA or protein. This diversity in the 
efficacy and mechanism of action of this class of compounds 
suggests that the activation of NF-tcB by IL-lfl in VSMC does 
not involve a redox-sensitive step. 
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